Kevin Kwei

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*”.

Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1907371

N/A

0.494DataRank · unranked

7 citations

Tycel Phillips, Leslie Popplewell, Sven de Vos, Saurabh Chhabra, Amy Kimball +8 more

B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3887

N/A

0.434DataRank · unranked

17 citations

Paolo Ghia, John C. Byrd, Inhye E. Ahn, Carol Moreno, Susan O’Brien +8 more